André B P van Kuilenburg

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Oxide Nanoparticles

Hypertrophic Cardiomyopathy

Replacement Therapy

Metastatic Colorectal Cancer

Top Venues

JCO precision oncology

Journal of inherited metabolic disease

This page only lists publications with an associated author ORCID identifier.

Publications

André B P van Kuilenburg, Marjolein C H Pleunis-van Empel, Rick B Brouwer, Angelique E J Sijben, Daan G Knapen, Thijs H Oude Munnink, Jelmer J van Zanden, Jenny Janssens-Puister, Doreen Dobritzsch, Rutger Meinsma, Judith Meijer-Jansen, Silvy J M van Dooren, Raymon Vijzelaar, Ana Pop, Gajja S Salomons, Jan Gerard Maring, Klary E Niezen-Koning
Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants. JCO precision oncology 8 (2024)
André B P van Kuilenburg, Marjolein C H Pleunis-van Empel, Rick B Brouwer, Angelique E J Sijben, Daan G Knapen, Thijs H Oude Munnink, Jelmer J van Zanden, Jenny Janssens-Puister, Doreen Dobritzsch, Rutger Meinsma, Judith Meijer-Jansen, Silvy J M van Dooren, Raymon Vijzelaar, Ana Pop, Gajja S Salomons, Jan Gerard Maring, Klary E Niezen-Koning
Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants. JCO precision oncology 8 (2024)
Eline C B Eskes, Laura van Dussen, Marion M M G Brands, Frederic M Vaz, Johannes M F G Aerts, André B P van Kuilenburg, Barbara Sjouke, Carla E M Hollak
Natural disease course of chronic visceral acid sphingomyelinase deficiency in adults: A first step toward treatment criteria. Journal of inherited metabolic disease (2024)
André B P van Kuilenburg, Carla E M Hollak, Ana Travella, Melisa Jacobs, Lucas D Gentilini, René Leen, Karen M M Ghauharali-van der Vlugt, Femke S Beers Stet, Susan M I Goorden, Sanne van der Veen, Marcelo Criscuolo, Mariana Papouchado
Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation. Drugs in R&D (2023)
Sanne J van der Veen, Mohamed El Sayed, Carla E M Hollak, Marion M M G Brands, C Khya S Snelder, S Matthijs Boekholdt, Liffert Vogt, Susan M I Goorden, André B P van Kuilenburg, Mirjam Langeveld
Early Risk Stratification for Natural Disease Course in Fabry Patients Using Plasma Globotriaosylsphingosine Levels. Clinical journal of the American Society of Nephrology : CJASN (2023)
André B P van Kuilenburg, Carla E M Hollak, Ana Travella, Melisa Jacobs, Lucas D Gentilini, René Leen, Karen M M Ghauharali-van der Vlugt, Femke S Beers Stet, Susan M I Goorden, Sanne van der Veen, Marcelo Criscuolo, Mariana Papouchado
Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation. Drugs in R&D (2023)
André B P van Kuilenburg, Carla E M Hollak, Ana Travella, Melisa Jacobs, Lucas D Gentilini, René Leen, Karen M M Ghauharali-van der Vlugt, Femke S Beers Stet, Susan M I Goorden, Sanne van der Veen, Marcelo Criscuolo, Mariana Papouchado
Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation. Drugs in R&D (2023)
André B P van Kuilenburg, Carla E M Hollak, Ana Travella, Melisa Jacobs, Lucas D Gentilini, René Leen, Karen M M Ghauharali-van der Vlugt, Femke S Beers Stet, Susan M I Goorden, Sanne van der Veen, Marcelo Criscuolo, Mariana Papouchado
Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation. Drugs in R&D (2023)
Iedan R N Verly, Yvette A H Matser, René Leen, Rutger Meinsma, Marta Fiocco, Jan Koster, Richard Volckmann, Dilara Savci-Heijink, Giuliana Cangemi, Sebastiano Barco, Linda J Valentijn, Godelieve A M Tytgat, André B P van Kuilenburg
Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma. JCO precision oncology 6 (2022)
Sanne J van der Veen, Wytze J Vlietstra, Laura van Dussen, André B P van Kuilenburg, Marcel G W Dijkgraaf, Malte Lenders, Eva Brand, Christoph Wanner, Derralynn Hughes, Perry M Elliott, Carla E M Hollak, Mirjam Langeveld
Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease. International journal of molecular sciences 21 (16) (2020)
Shanice Beerepoot, Silvy J M van Dooren, Gajja S Salomons, Jaap-Jan Boelens, Edwin H Jacobs, Marjo S van der Knaap, André B P van Kuilenburg, Nicole I Wolf
Metachromatic leukodystrophy genotypes in The Netherlands reveal novel pathogenic ARSA variants in non-Caucasian patients. Neurogenetics 21 (4) (2020)
André B P van Kuilenburg, Maja Tarailo-Graovac, Judith Meijer, Britt Drogemoller, Jerry Vockley, Dirk Maurer, Doreen Dobritzsch, Colin J Ross, Wyeth Wasserman, Rutger Meinsma, Lida Zoetekouw, Clara D M van Karnebeek
Genome sequencing reveals a novel genetic mechanism underlying dihydropyrimidine dehydrogenase deficiency: A novel missense variant c.1700G>A and a large intragenic inversion in DPYD spanning intron 8 to intron 12. Human mutation 39 (7) (2018)